| Identification | Back Directory | [Name]
5-Isoxazolecarboxamide, N-[[4-(4-methyl-1-piperazinyl)phenyl]methyl]- | [CAS]
883944-52-3 | [Synonyms]
SSAA09E2
5-Isoxazolecarboxamide, N-[[4-(4-methyl-1-piperazinyl)phenyl]methyl]-
domain,SARS-CoV,receptor,SSAA09E2,inhibit,SARS coronavirus,Inhibitor,spike,ACE2,binding,SSAA-09E2 | [Molecular Formula]
C16H20N4O2 | [MOL File]
883944-52-3.mol | [Molecular Weight]
300.36 |
| Chemical Properties | Back Directory | [Boiling point ]
571.2±50.0 °C(Predicted) | [density ]
1.202±0.06 g/cm3(Predicted) | [storage temp. ]
4°C, protect from light | [solubility ]
DMSO : 250 mg/mL (832.33 mM; Need ultrasonic) | [form ]
Solid | [pka]
13.60±0.46(Predicted) | [color ]
White to light yellow |
| Hazard Information | Back Directory | [Uses]
SSAA09E2 is an inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2) [1]. | [storage]
4°C, protect from light | [References]
[1] Bibi N, et al. Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19. Eur J Pharmacol. 2020;885:173496. DOI:10.1016/j.ejphar.2020.173496 |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310 |
| Website: |
www.weikeqi-biotech.com/ |
|